Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
LifeSprout
AddedFeb 17, 2024
UpdatedJun 18, 2026
LifeSprout

LifeSprout

Series A

LifeSprout: Pioneering synthetic soft tissue substitutes for aesthetic and regenerative medicine.

HQ
Baltimore, MD, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

LifeSprout, founded with a mission to revolutionize aesthetic and regenerative medicine, focuses on developing synthetic soft tissue substitutes. Their innovative platform mimics the body’s natural tissues, addressing soft tissue losses due to aging, cancer, and metabolic diseases. By leveraging breakthroughs in materials science, LifeSprout aims to provide minimally invasive solutions that enhance both form and function for millions of patients annually.

Notable figures affiliated with LifeSprout include leading experts in materials science and regenerative medicine. The company has attracted significant investment from prominent venture capital firms focused on healthcare innovation. Key achievements include the development of a versatile product suite that has the potential to transform patient outcomes in both aesthetic and reconstructive procedures. LifeSprout's impact is marked by its commitment to advancing medical technology and improving quality of life for patients worldwide.

LifeSprout - Similar Companies

inSoma Bio logo

inSoma Bio

insomabio.com

TissueForm logo

TissueForm

tissueforminc.com

Histogen logo

Histogen

histogen.com

BioAesthetics logo

BioAesthetics

bio-aesthetics.com

EternoGen logo

EternoGen

Synlife logo

Synlife

synlifebio.com

Tela Bio logo

Tela Bio

telabio.com

Blossom Innovations logo

Blossom Innovations

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Syntr Health Technologies logo

Syntr Health Technologies

syntrhealth.com

Gel4Med logo

Gel4Med

gelformed.com

BioRegenx logo

BioRegenx

bioregenx.com

Morphoceuticals logo

Morphoceuticals

LifeX logo

LifeX

lifex-labs.com

Elutia logo

Elutia

elutia.com

LifeSprout - Quick Facts

Who are LifeSprout's competitors?

Companies similar to LifeSprout include inSoma Bio, TissueForm, Histogen and BioAesthetics.

When was LifeSprout founded?

LifeSprout was founded in 2015.

Where is LifeSprout's headquarters located?

LifeSprout's headquarters is located in Baltimore, MD, US.

When was LifeSprout's last funding round?

LifeSprout's most recent funding round was for $28.5M (USD) in April 2020.

How much has LifeSprout raised to-date?

As of Apr 27, 2020, LifeSprout has raised a total of $35.8M (USD).

How many employees does LifeSprout have?

LifeSprout has 10 employees as of Feb 5, 2024.

LifeSprout - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Devices
  • Soft Tissue
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified